Probioticaprofylaxe bij voorspeld ernstige acute pancreatitis: een gerandomiseerde, dubbelblinde, placebogecontroleerde trial
Marc G. Besselink(Amsterdam Neuroscience), H. G. Gooszen, Hjalmar C. van Santvoort(University Medical Center Utrecht), Harro M. Timmerman, E. van der Harst, Camiel Rosman(Radboud University Nijmegen), Marja A. Boermeester(Amsterdam University Medical Centers), Rutger J. Ploeg(University of Oxford), Ben Witteman(Ziekenhuis Gelderse Vallei), Harry van Goor(Radboud University Nijmegen), Alexander F. Schaapherder, Miguel A. Cuesta(Hospital General Universitario de Albacete), Bert van Ramshorst(St. Antonius Ziekenhuis), Menno A. Brink, Cornelis H.C. Dejong(Maastricht University), Erik Buskens(Radboud University Nijmegen), Thomas L. Bollen(St. Antonius Ziekenhuis), L. M. A. Akkermans, C.J.H.M. van Laarhoven(Radboud University Nijmegen), Vincent B. Nieuwenhuijs(Isala), Peter J. Wahab, Casper H.J. van Eijck(Erasmus MC)
Research Publications (Maastricht University)
January 1, 2008
Cited by 2
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival
|Journal of Clinical Oncology|2008|1.4k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914